Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 9, Pages 1039
Publisher
MDPI AG
Online
2022-08-24
DOI
10.3390/ph15091039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
- (2021) Ludwig Aigner et al. Frontiers in Molecular Biosciences
- The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
- (2021) Johanna Michael et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microglia and Neuroinflammation: What Place for P2RY12?
- (2021) Albert Gómez Morillas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Montelukast in hospitalized patients diagnosed with COVID-19
- (2021) Ahsan R. Khan et al. JOURNAL OF ASTHMA
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Repurposing: Claiming the Full Benefit from Drug Development
- (2021) Eric Kort et al. Current Cardiology Reports
- A Boxed Warning for Montelukast: The FDA Perspective
- (2021) Katherine Clarridge et al. Journal of Allergy and Clinical Immunology-In Practice
- OATP2B1 – The underrated member of the organic anion transporting polypeptide family of drug transporters?
- (2021) Jonny Kinzi et al. BIOCHEMICAL PHARMACOLOGY
- Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
- (2021) Johan Wallin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trends and patterns of neurotology drug prescriptions on a nationwide insurance database
- (2021) Khodayar Goshtasbi et al. Laryngoscope Investigative Otolaryngology
- Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension
- (2021) Andrea Trost et al. EXPERIMENTAL EYE RESEARCH
- The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
- (2020) Julia Marschallinger et al. Neurotherapeutics
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
- (2020) Angela Dziedzic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/KATP channel pathway and PPARγ receptors
- (2020) Ehsan Alizamani et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Organic anion transporting polypeptide 2B1 (OATP2B1), an expanded substrate profile, does it align with OATP2B1’s hypothesized function?
- (2020) Dallas Bednarczyk et al. XENOBIOTICA
- Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases
- (2020) Adam Armada-Moreira et al. Frontiers in Cellular Neuroscience
- Montelukast in children with allergic rhinitis amid COVID‐19 pandemic
- (2020) Chia Siang Kow et al. ACTA PAEDIATRICA
- Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
- (2020) Dennis C. Copertino et al. JOURNAL OF MEDICAL VIROLOGY
- A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
- (2020) Colin D. Funk et al. Frontiers in Pharmacology
- Risk of Psychiatric Adverse Events among Montelukast Users
- (2020) Veronica V. Sansing-Foster et al. Journal of Allergy and Clinical Immunology-In Practice
- Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
- (2020) Nitesh Sanghai et al. DRUG DISCOVERY TODAY
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- A possible effect of montelukast on neurological aging examined by the use of register data
- (2020) Bjørn Grinde et al. International Journal of Clinical Pharmacy
- A GPR17-cAMP-Lactate Signaling Axis in Oligodendrocytes Regulates Whole-Body Metabolism
- (2019) Zhimin Ou et al. Cell Reports
- Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case–Control Study
- (2019) S. Dresden Glockler-Lauf et al. JOURNAL OF PEDIATRICS
- Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy
- (2019) Natalia N. Nalivaeva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
- (2019) Sneham Tiwari et al. International Journal of Nanomedicine
- α-synuclein in the pathophysiology of Alzheimer’s disease
- (2019) Daniel Twohig et al. Molecular Neurodegeneration
- Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases
- (2019) Yuxi Wang et al. NEUROBIOLOGY OF AGING
- Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
- (2019) Carroll Rutherford Fields et al. Frontiers in Molecular Neuroscience
- Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells
- (2018) Caixia Tang et al. CANCER BIOLOGY & THERAPY
- Leukotriene receptors as potential therapeutic targets
- (2018) Takehiko Yokomizo et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of montelukast in experimental model of Parkinson’s disease
- (2018) Vetrivel Babu Nagarajan et al. NEUROSCIENCE LETTERS
- Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy
- (2018) Shu-Hui Xin et al. NEUROTOXICITY RESEARCH
- Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial
- (2018) David Ruttens et al. PLoS One
- An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
- (2018) Stephen D. Skaper et al. Frontiers in Cellular Neuroscience
- Receptors of intermediates of carbohydrate metabolism, GPR91 and GPR99, mediate axon growth
- (2018) Hosni Cherif et al. PLOS BIOLOGY
- The leukotriene signaling pathway: a druggable target in Alzheimer’s disease
- (2018) Johanna Michael et al. DRUG DISCOVERY TODAY
- Targeting Cysteinyl-Leukotrienes in Abdominal Aortic Aneurysm
- (2018) Ana Carolina Araújo et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects
- (2018) Riham M. Mansour et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Montelukast in chronic lung allograft dysfunction after lung transplantation
- (2018) Robin Vos et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma
- (2018) Hoang Kim Tu Trinh et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice
- (2017) Brigitte Benard et al. EUROPEAN RESPIRATORY JOURNAL
- Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells
- (2017) Ming-Ju Tsai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparison of neurotoxicity of different aggregated forms of Aβ 40, Aβ 42 and Aβ 43 in cell cultures
- (2017) Lu Fu et al. JOURNAL OF PEPTIDE SCIENCE
- Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
- (2017) Paolo Gelosa et al. MEDIATORS OF INFLAMMATION
- Not just amyloid: physiological functions of the amyloid precursor protein family
- (2017) Ulrike C. Müller et al. NATURE REVIEWS NEUROSCIENCE
- Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls
- (2017) Céline Bellenguez et al. NEUROBIOLOGY OF AGING
- Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson’s disease
- (2017) Hannah Jang et al. NEUROREPORT
- Pathology of Neurodegenerative Diseases
- (2017) Brittany N. Dugger et al. Cold Spring Harbor Perspectives in Biology
- Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
- (2017) Panchanan Maiti et al. Translational Neurodegeneration
- Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in Denmark
- (2017) Clara Cavero-Carbonell et al. Birth Defects Research
- Unsung renal receptors: orphan G-protein-coupled receptors play essential roles in renal development and homeostasis
- (2016) P. Rajkumar et al. Acta Physiologica
- A dual CysLT1/2antagonist attenuates allergen-induced airway responses in subjects with mild allergic asthma
- (2016) G. M. Gauvreau et al. ALLERGY
- Montelukast-induced metamorphopsia in a pediatric patient
- (2016) Carla Carnovale et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- 6-Shogaol has anti-amyloidogenic activity and ameliorates Alzheimer’s disease via CysLT1R-mediated inhibition of cathepsin B
- (2016) Ji-Young Na et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling
- (2016) Xiaoyu Liu et al. BRAIN BEHAVIOR AND IMMUNITY
- Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders
- (2016) Arijit Ghosh et al. CNS Neuroscience & Therapeutics
- Neuroinflammation pathways: a general review
- (2016) Tara Shabab et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Neuroinflammation: the devil is in the details
- (2016) Damon J. DiSabato et al. JOURNAL OF NEUROCHEMISTRY
- Altered Proteins in the Aging Brain
- (2016) Adila Elobeid et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Ageing, neurodegeneration and brain rejuvenation
- (2016) Tony Wyss-Coray NATURE
- An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration
- (2016) Geoffrey Burnstock NEUROPHARMACOLOGY
- Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice
- (2016) Chun Teng Zhang et al. NEUROTOXICOLOGY
- Modulation of LOX and COX pathways via inhibition of amyloidogenesis contributes to mitoprotection against β-amyloid oligomer-induced toxicity in an animal model of Alzheimer's disease in rats
- (2016) Jaspreet Kalra et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
- (2016) Janina Grosch et al. Frontiers in Cellular Neuroscience
- Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
- (2016) Ming-Ju Tsai et al. Scientific Reports
- Serotonin in Parkinson's disease
- (2015) Marios Politis et al. BEHAVIOURAL BRAIN RESEARCH
- CysLT 2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro
- (2015) Lu Chen et al. BRAIN RESEARCH
- Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase®
- (2015) Ana Aldea Perona et al. DRUG SAFETY
- P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma
- (2015) Dong-Hyeon Suh et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma
- (2015) Satoshi Itadani et al. JOURNAL OF MEDICINAL CHEMISTRY
- HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats
- (2015) Q.J. Shi et al. NEUROSCIENCE
- Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice
- (2015) Xu-Ben Yu et al. PSYCHOPHARMACOLOGY
- Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
- (2015) Julia Marschallinger et al. Nature Communications
- Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors
- (2015) Katie J. Herbst-Robinson et al. Scientific Reports
- The role of leukotrienes in allergic diseases
- (2015) Min Liu et al. ALLERGOLOGY INTERNATIONAL
- Montelukast Disposition: No Indication of Transporter-Mediated Uptake in OATP2B1 and OATP1B1 Expressing HEK293 Cells
- (2015) Marie Brännström et al. Pharmaceutics
- Effect of Concomitant Use of Montelukast and Efavirenz on Neuropsychiatric Adverse Events
- (2014) Olatz Ibarra-Barrueta et al. ANNALS OF PHARMACOTHERAPY
- Kinetic characteristics of euflammation: The induction of controlled inflammation without overt sickness behavior
- (2014) Andrew J. Tarr et al. BRAIN BEHAVIOR AND IMMUNITY
- Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1
- (2014) Xiao-Yan Zhang et al. BRAIN RESEARCH
- Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist Protects Against Hippocampal Injury Induced by Transient Global Cerebral Ischemia and Reperfusion in Rats
- (2014) M. A. Saad et al. NEUROCHEMICAL RESEARCH
- Montelukast rescues primary neurons against Aβ1–42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling
- (2014) Jin’e Lai et al. NEUROCHEMISTRY INTERNATIONAL
- Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice
- (2014) Jin'e Lai et al. NEUROPHARMACOLOGY
- Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood–brain barrier dysfunction
- (2014) Q.F. Lenz et al. NEUROSCIENCE
- Leukotriene receptor antagonists in Henoch-Schönlein syndrome: Friends or foes?
- (2014) Pietro Camozzi et al. PEDIATRICS INTERNATIONAL
- Montelukast-Induced Adverse Drug Reactions: A Review of Case Reports in the Literature
- (2014) Gioacchino Calapai et al. PHARMACOLOGY
- Asthma during Pregnancy in a Population-Based Study - Pregnancy Complications and Adverse Perinatal Outcomes
- (2014) Gustaf Rejnö et al. PLoS One
- Hepatotoxicity caused by montelukast in a paediatric patient
- (2014) Dariusz M. Lebensztejn et al. Przeglad Gastroenterologiczny
- Montelukast sodium-induced hematuria: a case report and literature review of 19 cases in mainland China
- (2013) Jian-Xiang Xie et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- A review on leukotrienes and their receptors with reference to asthma
- (2013) Rakesh Kumar Singh et al. JOURNAL OF ASTHMA
- Norepinephrine Modulates the Motility of Resting and Activated Microglia via Different Adrenergic Receptors
- (2013) Stefka Gyoneva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of GPR99 Protein as a Potential Third Cysteinyl Leukotriene Receptor with a Preference for Leukotriene E4Ligand
- (2013) Yoshihide Kanaoka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stress-Induced Recruitment of Bone Marrow-Derived Monocytes to the Brain Promotes Anxiety-Like Behavior
- (2013) E. S. Wohleb et al. JOURNAL OF NEUROSCIENCE
- Involvement of cysteinyl leukotriene receptor 1 in Aβ1–42-induced neurotoxicity in vitro and in vivo
- (2013) Su-Su Tang et al. NEUROBIOLOGY OF AGING
- Leukotriene D4 induces amyloid-β generation via CysLT1R-mediated NF-κB pathways in primary neurons
- (2013) Xiao Yun Wang et al. NEUROCHEMISTRY INTERNATIONAL
- Protection of dopaminergic neurons by 5-lipoxygenase inhibitor
- (2013) Kai-Hsiang Kang et al. NEUROPHARMACOLOGY
- Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury
- (2013) Heike Franke et al. Purinergic Signalling
- Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist
- (2013) S. Hennen et al. Science Signaling
- Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
- (2013) E.-M. Mandelkow et al. Cold Spring Harbor Perspectives in Medicine
- Un caso de síndrome de Alicia en el país de las maravillas en probable relación con el uso de montelukast
- (2012) E. Bernal Vañó et al. ANALES DE PEDIATRIA
- The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
- (2012) Masaaki Iwata et al. BRAIN BEHAVIOR AND IMMUNITY
- The leukotriene receptor antagonist montelukast and aortic stenosis
- (2012) Magnus Bäck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production
- (2012) Mai M. Helmy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease
- (2012) Erik Ingelsson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: A nested case-control study
- (2012) Glen T. Schumock et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Leukotriene D4 induces cognitive impairment through enhancement of CysLT1R-mediated amyloid-β generation in mice
- (2012) Su-Su Tang et al. NEUROPHARMACOLOGY
- Quercetin and Sesamin Protect Dopaminergic Cells from MPP+-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System
- (2012) Julie Bournival et al. Oxidative Medicine and Cellular Longevity
- Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes
- (2012) S J Sukoff Rizzo et al. Translational Psychiatry
- Cerebral amyloid angiopathy in the elderly
- (2011) Anand Viswanathan et al. ANNALS OF NEUROLOGY
- Leukotriene Receptors
- (2011) Motonao Nakamura et al. CHEMICAL REVIEWS
- Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations
- (2011) A. M. Filppula et al. DRUG METABOLISM AND DISPOSITION
- Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate
- (2011) B. M. VandenBrink et al. DRUG METABOLISM AND DISPOSITION
- Clinical effects and outcomes with new P2Y12 inhibitors in ACS
- (2011) Jean-Philippe Collet et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in rats
- (2011) Ghada M. Suddek FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications
- (2011) Linda M. Nelsen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phenotypic Changes, Signaling Pathway, and Functional Correlates of GPR17-expressing Neural Precursor Cells during Oligodendrocyte Differentiation
- (2011) Marta Fumagalli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antiasthmatic Drugs Targeting the Cysteinyl Leukotriene Receptor 1 Alleviate Central Nervous System Inflammatory Cell Infiltration and Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2011) L. Wang et al. JOURNAL OF IMMUNOLOGY
- A Selective Cysteinyl Leukotriene Receptor 2 Antagonist Blocks Myocardial Ischemia/Reperfusion Injury and Vascular Permeability in Mice
- (2011) N. C. Ni et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats
- (2011) Rui Zhao et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- A Case of Churg-Strauss Syndrome Treated with Montelukast
- (2011) Ceyda Anar et al. MEDICAL PRINCIPLES AND PRACTICE
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
- (2011) Adam C Naj et al. NATURE GENETICS
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
- (2011) Paul Hollingworth et al. NATURE GENETICS
- Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation
- (2011) Young C. Chung et al. NEUROPHARMACOLOGY
- Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats
- (2011) C.Z. Zhao et al. NEUROSCIENCE
- The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats
- (2011) B. Zhao et al. NEUROSCIENCE
- Modulation of leukotriene D4 attenuates the development of seizures in mice
- (2011) Ashish K. Rehni et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study
- (2011) Geert M. Verleden et al. TRANSPLANT INTERNATIONAL
- MONTELUKAST-ASSOCIATED CHURG-STRAUSS VASCULITIS: ANOTHER ASSOCIATED REPORT
- (2010) Jonathan G. Black et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor
- (2010) F Wunder et al. BRITISH JOURNAL OF PHARMACOLOGY
- Churg–Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antagonist
- (2010) Takahiro Kanda et al. Clinical and Experimental Nephrology
- Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice
- (2010) Chiko Shimbori et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules
- (2010) Josiane S. Neves et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- GPR17 Regulates Immune Pulmonary Inflammation Induced by House Dust Mites
- (2010) A. Maekawa et al. JOURNAL OF IMMUNOLOGY
- The secretases: enzymes with therapeutic potential in Alzheimer disease
- (2010) Bart De Strooper et al. Nature Reviews Neurology
- Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats
- (2010) H. Kalonia et al. NEUROSCIENCE
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics
- (2010) R.K. Singh et al. PHARMACOLOGY
- Possible montelukast-induced angioedema
- (2009) R. Sabbagh et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPγS binding and electrophysiological studies in 1321N1 cells
- (2009) Anna Maria Pugliese et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury
- (2009) Stefania Ceruti et al. BRAIN
- Churg-Strauss syndrome secondary to antileucotriene therapy in a patient not receiving oral corticosteroids
- (2009) L. Jennings et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis
- (2009) Magnus Back CURRENT PHARMACEUTICAL DESIGN
- Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes
- (2009) Moumita Sarkar et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Suicidality and montelukast
- (2009) Partam Manalai et al. Expert Opinion On Drug Safety
- Reports of suicidality in clinical trials of montelukast
- (2009) George Philip et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Churg-Strauss Syndrome Associated with Montelukast Therapy
- (2009) Dusanka Martinović Kaliterna et al. JOURNAL OF ASTHMA
- Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: A novel role of the cysteinyl LT-1 receptor
- (2009) John J. Wixted et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12receptor
- (2009) Sailaja Paruchuri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes
- (2009) Valérie Capra et al. JOURNAL OF LIPID RESEARCH
- Montelukast induced acute hepatocellular liver injury
- (2009) G Parthasarathi et al. Journal of Postgraduate Medicine
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Montelukast and psychiatric disorders in children
- (2009) Susanna M. Wallerstedt et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response
- (2009) Edward B. Mougey et al. Pharmacogenetics and Genomics
- Rate of Suicide in Patients Taking Montelukast
- (2009) Hershel Jick et al. PHARMACOTHERAPY
- GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4
- (2009) Akiko Maekawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leukotriene Signaling in Atherosclerosis and Ischemia
- (2008) Magnus Bäck CARDIOVASCULAR DRUGS AND THERAPY
- Montelukast inhibits tumour necrosis factor-α-mediated interleukin-8 expression through inhibition of nuclear factor-κB p65-associated histone acetyltransferase activity
- (2008) F. Tahan et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1 , Interleukin-6, and Tumor Necrosis Factor- in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord
- (2008) Y. Kawasaki et al. JOURNAL OF NEUROSCIENCE
- Origin and physiological roles of inflammation
- (2008) Ruslan Medzhitov NATURE
- Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice
- (2008) Tolga Uz et al. NEUROSCIENCE LETTERS
- MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
- (2008) Jyothi K. Mallajosyula et al. PLoS One
- Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
- (2008) Igor F. Tsigelny et al. PLoS One
- The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair
- (2008) Davide Lecca et al. PLoS One
- The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study
- (2008) T Hauser et al. THORAX
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation